Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: The KID study

Sung Eun Lee, Soo Young Choi, Hye Young Song, Soo Hyun Kim, Mi Yeon Choi, Joon Seong Park, Hyeoung Joon Kim, Sung Hyun Kim, Dae Young Zang, Sukjoong Oh, Hawk Kim, Young Rok Do, Jae Yong Kwak, Jeong A. Kim, Dae Young Kim, Yeung Chul Mun, Won Sik Lee, Myung Hee Chang, Jinny Park, Ji Hyun KwonDong Wook Kim

Research output: Contribution to journal › Article › peer-review

143 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: The KID study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology